172 related articles for article (PubMed ID: 16846534)
1. MUC1 alters oncogenic events and transcription in human breast cancer cells.
Hattrup CL; Gendler SJ
Breast Cancer Res; 2006; 8(4):R37. PubMed ID: 16846534
[TBL] [Abstract][Full Text] [Related]
2. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
3. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.
Wei X; Xu H; Kufe D
Cancer Res; 2007 Feb; 67(4):1853-8. PubMed ID: 17308127
[TBL] [Abstract][Full Text] [Related]
4. MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells.
Siragusa M; Zerilli M; Iovino F; Francipane MG; Lombardo Y; Ricci-Vitiani L; Di Gesù G; Todaro M; De Maria R; Stassi G
Cancer Res; 2007 Jun; 67(11):5522-30. PubMed ID: 17545635
[TBL] [Abstract][Full Text] [Related]
5. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
Abba MC; Nunez MI; Colussi AG; Croce MV; Segal-Eiras A; Aldaz CM
Breast Cancer Res; 2006; 8(6):R64. PubMed ID: 17078870
[TBL] [Abstract][Full Text] [Related]
6. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
[TBL] [Abstract][Full Text] [Related]
7. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.
Wei X; Xu H; Kufe D
Mol Cell; 2006 Jan; 21(2):295-305. PubMed ID: 16427018
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implication.
Koga T; Kuwahara I; Lillehoj EP; Lu W; Miyata T; Isohama Y; Kim KC
Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L693-701. PubMed ID: 17575006
[TBL] [Abstract][Full Text] [Related]
9. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
[TBL] [Abstract][Full Text] [Related]
10. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling.
Kondo S; Yoshizaki T; Wakisaka N; Horikawa T; Murono S; Jang KL; Joab I; Furukawa M; Pagano JS
J Virol; 2007 Feb; 81(4):1554-62. PubMed ID: 17151127
[TBL] [Abstract][Full Text] [Related]
11. MUC1 inhibits cell proliferation by a beta-catenin-dependent mechanism.
Lillehoj EP; Lu W; Kiser T; Goldblum SE; Kim KC
Biochim Biophys Acta; 2007 Jul; 1773(7):1028-38. PubMed ID: 17524503
[TBL] [Abstract][Full Text] [Related]
12. Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis.
Escher TE; Lui AJ; Geanes ES; Walter KR; Tawfik O; Hagan CR; Lewis-Wambi J
Mol Cancer Res; 2019 May; 17(5):1180-1194. PubMed ID: 30655323
[TBL] [Abstract][Full Text] [Related]
13. Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways.
Thompson EJ; Shanmugam K; Hattrup CL; Kotlarczyk KL; Gutierrez A; Bradley JM; Mukherjee P; Gendler SJ
Mol Cancer Res; 2006 Jul; 4(7):489-97. PubMed ID: 16849524
[TBL] [Abstract][Full Text] [Related]
14. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
16. MUC1 cytoplasmic tail: a potential therapeutic target for ovarian carcinoma.
Hu XF; Yang E; Li J; Xing PX
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1261-71. PubMed ID: 16925492
[TBL] [Abstract][Full Text] [Related]
17. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
18. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
19. Suppression of MUC1 synthesis downregulates expression of the epidermal growth factor receptor.
Li X; Wang L; Nunes DP; Troxler RF; Offner GD
Cancer Biol Ther; 2005 Sep; 4(9):968-73. PubMed ID: 16082192
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
